[go: up one dir, main page]

PL196501A1 - METHOD OF MANUFACTURING OPTICALLY ACTIVE CEPHALOSPORINE L-ISOMER - Google Patents

METHOD OF MANUFACTURING OPTICALLY ACTIVE CEPHALOSPORINE L-ISOMER

Info

Publication number
PL196501A1
PL196501A1 PL19650177A PL19650177A PL196501A1 PL 196501 A1 PL196501 A1 PL 196501A1 PL 19650177 A PL19650177 A PL 19650177A PL 19650177 A PL19650177 A PL 19650177A PL 196501 A1 PL196501 A1 PL 196501A1
Authority
PL
Poland
Prior art keywords
cephalosporine
isomer
optically active
manufacturing optically
manufacturing
Prior art date
Application number
PL19650177A
Other languages
Polish (pl)
Inventor
Herman Breuer
Uwa D Treuner
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/664,796 external-priority patent/US4088816A/en
Priority claimed from US05/664,795 external-priority patent/US4088815A/en
Priority claimed from US05/764,134 external-priority patent/US4127716A/en
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of PL196501A1 publication Critical patent/PL196501A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36Methylene radicals, substituted by sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL19650177A 1976-03-08 1977-03-08 METHOD OF MANUFACTURING OPTICALLY ACTIVE CEPHALOSPORINE L-ISOMER PL196501A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US05/664,796 US4088816A (en) 1974-09-20 1976-03-08 3-Heterothio substituted 7-(ureido-heteroacetyl) cephalosporins
US05/664,795 US4088815A (en) 1974-09-20 1976-03-08 3-Heterothio-7-ureido cephalosporins
US05/764,134 US4127716A (en) 1976-03-08 1977-02-02 3-heterothiomethyl ureido cephalosporins

Publications (1)

Publication Number Publication Date
PL196501A1 true PL196501A1 (en) 1978-02-13

Family

ID=27418117

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19650177A PL196501A1 (en) 1976-03-08 1977-03-08 METHOD OF MANUFACTURING OPTICALLY ACTIVE CEPHALOSPORINE L-ISOMER

Country Status (16)

Country Link
JP (1) JPS52108996A (en)
AT (1) AT352876B (en)
AU (1) AU2236777A (en)
CA (1) CA1088517A (en)
CS (1) CS191190B2 (en)
DD (1) DD129793A5 (en)
DE (1) DE2707812A1 (en)
DK (1) DK97077A (en)
ES (1) ES456591A1 (en)
FR (1) FR2343745A2 (en)
GB (1) GB1573786A (en)
NL (1) NL7702405A (en)
NZ (1) NZ183332A (en)
PL (1) PL196501A1 (en)
PT (1) PT66272B (en)
SE (1) SE7702558L (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2927534A1 (en) * 1979-07-07 1981-01-08 Bayer Ag OPTICALLY PURE HETEROCYCLIC AMINO ACIDS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE

Also Published As

Publication number Publication date
ATA155177A (en) 1979-03-15
SE7702558L (en) 1977-09-09
DD129793A5 (en) 1978-02-08
AU2236777A (en) 1978-08-24
DK97077A (en) 1977-09-09
PT66272A (en) 1977-03-31
CS191190B2 (en) 1979-06-29
FR2343745A2 (en) 1977-10-07
DE2707812A1 (en) 1977-09-15
PT66272B (en) 1978-08-08
GB1573786A (en) 1980-08-28
AT352876B (en) 1979-10-10
NL7702405A (en) 1977-09-12
NZ183332A (en) 1979-10-25
CA1088517A (en) 1980-10-28
JPS52108996A (en) 1977-09-12
ES456591A1 (en) 1978-02-16

Similar Documents

Publication Publication Date Title
PL199748A1 (en) METHOD OF SELECTIVELY MANUFACTURING P-DUALKILOBENZENOW
PL199362A1 (en) METHOD OF STEREOSELECTIVE PRODUCTION OF OPTICALLY ACTIVE SIXHYDUBENZOPYRANONE ISOMERS
PL201666A1 (en) METHOD OF MANUFACTURING LIPOSOMES
NL7704136A (en) CONTACT LENS AND METHOD OF MANUFACTURE THEREOF.
DK20376A (en) METHOD OF MANUFACTURE OF OPTICALLY ACTIVE ANTHRACYCLINONS
BR7703500A (en) METHOD OF MANUFACTURING OPTICAL FIBERS
PL201837A1 (en) METHOD OF MANUFACTURING CINO-ORGANIC COMPOUNDS
PL199798A1 (en) METHOD OF MAKING GAMMA-PYRONY
GB1546015A (en) Racemization of optically active compound
PL199298A1 (en) METHOD OF MAKING 2-BROMO-6-FLUORO-N-2-IMIDAZOLIDINYLIDENE-BENZAMINE
PL196008A1 (en) METHOD OF MANUFACTURING BIOLOGICALLY ACTIVE POLYMERS
PL196820A1 (en) METHOD OF PRODUCTION OF 3-CHLOROCOMETHYL CEPHEMIC COMPOUNDS-3
DK275277A (en) METHOD OF MANUFACTURE OF OPTIC ACTIVE ALLETHROLONE
PL201885A1 (en) METHOD OF MANUFACTURING 4A-ARYL-OCTIAHYDROGEN-1H-2-PYRINDINE
DK265977A (en) OPTICALLY ACTIVE ANTHRACYCLINONS
IT1079936B (en) PROCEDURE FOR THE PRODUCTION OF OPTICALLY ACTIVE ALLETROLONE
PL199633A1 (en) METHOD OF MAKING 5-M-TOLYLOXYURACYL
PL202091A1 (en) METHOD OF MAKING GAMMA-PYRONOW
PL195886A1 (en) METHOD OF MANUFACTURING AN ACTIVE SUBSTANCE
PL201839A1 (en) METHOD OF MANUFACTURING CINO-ORGANIC COMPOUNDS
PL202402A1 (en) METHOD OF MANUFACTURING 6-AMINOPENICYLIC ACID
PL196501A1 (en) METHOD OF MANUFACTURING OPTICALLY ACTIVE CEPHALOSPORINE L-ISOMER
JPS52111537A (en) Production of optically active phenyl glycine
PL199367A1 (en) METHOD OF STERE-SELECTIVE PRODUCTION OF OPTICALLY ACTIVE 6A, 10A-TRANS-SIXO-HYDROGENDUBENZOPYRANONE
PL209408A1 (en) METHOD OF MAKING OPTICALLY ACTIVE GUANIDINE PANTONATE